101 related articles for article (PubMed ID: 11294072)
21. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
22. [Attention deficit hyperactivity disorder].
Banaschewski T; Konrad K; Rothenberger A; Hebebrand J
Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):250-65. PubMed ID: 20306781
[No Abstract] [Full Text] [Related]
23. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
24. [Follow-up of the MTA-study in children with ADHD: what do the data tell us, and what not?].
Buitelaar JK
Tijdschr Psychiatr; 2010; 52(4):255-7. PubMed ID: 20503166
[No Abstract] [Full Text] [Related]
25. Psychosocial treatments for ADHD in teens and adults: a practice-friendly review.
Murphy K
J Clin Psychol; 2005 May; 61(5):607-19. PubMed ID: 15723366
[TBL] [Abstract][Full Text] [Related]
26. Psychosocial interventions. Individual psychotherapy with the child, and family interventions.
Stubbe DE; Weiss G
Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):663-70, ix. PubMed ID: 10944661
[TBL] [Abstract][Full Text] [Related]
27. Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.
Laforett DR; Murray DW; Kollins SH
Dev Disabil Res Rev; 2008; 14(4):300-10. PubMed ID: 19072758
[TBL] [Abstract][Full Text] [Related]
28. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
29. Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.
Vaughan BS; Wetzel MW; Kratochvil CJ
Int Rev Psychiatry; 2008 Apr; 20(2):143-9. PubMed ID: 18386204
[TBL] [Abstract][Full Text] [Related]
30. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
31. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
32. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
[TBL] [Abstract][Full Text] [Related]
33. Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia.
Al-Haidar FA
East Mediterr Health J; 2003; 9(5-6):988-95. PubMed ID: 16450529
[TBL] [Abstract][Full Text] [Related]
34. A conceptual model of child psychopathology: implications for understanding attention deficit hyperactivity disorder and treatment efficacy.
Rapport MD; Chung KM; Shore G; Isaacs P
J Clin Child Psychol; 2001 Mar; 30(1):48-58. PubMed ID: 11294077
[TBL] [Abstract][Full Text] [Related]
35. Primary care treatment of attention-deficit/hyperactivity disorder.
Culpepper L
J Clin Psychiatry; 2006; 67 Suppl 8():51-8. PubMed ID: 16961431
[TBL] [Abstract][Full Text] [Related]
36. Multimodal treatments for childhood attention-deficit/hyperactivity disorder: interpreting outcomes in the context of study designs.
Hoza B; Kaiser NM; Hurt E
Clin Child Fam Psychol Rev; 2007 Dec; 10(4):318-34. PubMed ID: 17710545
[TBL] [Abstract][Full Text] [Related]
37. Implications for Australia of the multimodal treatment study of children with attention-deficit/hyperactivity disorder.
Levy F
Aust N Z J Psychiatry; 2001 Feb; 35(1):45-8. PubMed ID: 11270455
[TBL] [Abstract][Full Text] [Related]
38. Lessons from large trials: the MTA study as a model for evaluating the treatment of childhood psychiatric disorder.
Boyle MH; Jadad AR
Can J Psychiatry; 1999 Dec; 44(10):991-8. PubMed ID: 10637678
[TBL] [Abstract][Full Text] [Related]
39. The NIMH multimodal treatment study for attention-deficit hyperactivity disorder: just say yes to drugs alone?
Pelham WE
Can J Psychiatry; 1999 Dec; 44(10):981-90. PubMed ID: 10637677
[TBL] [Abstract][Full Text] [Related]
40. Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation.
Wells KC; Pelham WE; Kotkin RA; Hoza B; Abikoff HB; Abramowitz A; Arnold LE; Cantwell DP; Conners CK; Del Carmen R; Elliott G; Greenhill LL; Hechtman L; Hibbs E; Hinshaw SP; Jensen PS; March JS; Swanson JM; Schiller E
J Abnorm Child Psychol; 2000 Dec; 28(6):483-505. PubMed ID: 11104313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
